Li Xiulan agreed to acquire a 5% stake in Hybio Pharmaceutical Co., Ltd. (SZSE : 300199) from Zeng Shaogui, Zeng Shaoqiang and Zeng Shaobin for approximately CNY 450 million on February 13, 2023. Under the terms, Li Xiulan will pay CNY 10.248 per share in cash for the 44 million shares of Hybio Pharmaceutical. Zeng Shaogui will transfer 19.50 million shares (2.21% stake), Zeng Shaoqiang will transfer 18,412,066 shares (2.08% stake), Zeng Shaobin will transfer 6,250,000 shares (0.71% stake).

Li Xiulan completed the acquisition of 5% stake in Hybio Pharmaceutical Co., Ltd. (SZSE : 300199) from Zeng Shaogui, Zeng Shaoqiang and Zeng Shaobin on March 28, 2023.